Related Experiment Video
Updated: Sep 1, 2025
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Modulation of osteoblast differentiation and function by the P2X4 receptor
Isabel R Orriss1, Bethan K Davies2, Lucie E Bourne2
1Department of Comparative Biomedical Sciences, Royal Veterinary College, Royal College Street, London, NW1 0TU, UK. iorriss@rvc.ac.uk.
Abstract:
Bone cells are known to express multiple P2 receptor subtypes, and the functional effects of receptor activation have been described for many of these. One exception is the P2X4 receptor, which despite strong expression in osteoblasts and osteoclasts, has no defined functional activity. This study used the selective P2X4 receptor antagonists, 5-BDBD and PSB-12062, to investigate the role of this receptor in bone. Both antagonists (≥ 0.1 μM) dose-dependently decreased bone formation by 60-100%. This was accompanied by a ≤ 70% decrease in alkaline phosphatase activity, a ≤ 40% reduction in cell number, and a ≤ 80% increase in the number of adipocytes present in the culture. The analysis of gene expression showed that levels of osteoblast marker genes (e.g. Alpl, Bglap) were decreased in 5-BDBD treated cells. Conversely, expression of the adipogenic transcription factor PPARG was increased 10-fold. In osteoclasts, high doses of both antagonists were associated with a reduction in osteoclast formation and resorptive activity by ≤ 95% and ≤ 90%, respectively. Taken together, these data suggest that the P2X4 receptor plays a role in modulating bone cell function. In particular, it appears to influence osteoblast differentiation favouring the osteogenic lineage over the adipogenic lineage.
Insights
The P2X4 receptor influences bone cell function, promoting osteoblast differentiation and inhibiting adipocyte formation. Blocking this receptor impairs bone formation and osteoclast activity.
Area of Science:
- Bone Biology
- Cell Signaling
- Receptor Pharmacology
Background:
- Bone cells express various P2 receptor subtypes with known functions.
- The P2X4 receptor is highly expressed in osteoblasts and osteoclasts, but its function remains undefined.
Purpose of the Study:
- To investigate the functional role of the P2X4 receptor in bone cells using selective antagonists.
- To determine the effect of P2X4 receptor blockade on osteoblast and osteoclast activity.
Main Methods:
- Utilized selective P2X4 receptor antagonists (5-BDBD and PSB-12062).
- Assessed effects on osteoblast differentiation, alkaline phosphatase activity, cell number, and adipocyte differentiation.
- Analyzed gene expression of osteoblast markers and adipogenic transcription factors.
- Evaluated osteoclast formation and resorptive activity.
Main Results:
- P2X4 receptor antagonists dose-dependently decreased bone formation (60-100%).
- Inhibition of alkaline phosphatase activity and osteoblast marker gene expression was observed.
- Increased adipocyte differentiation and PPARG expression occurred with antagonist treatment.
- Osteoclast formation and resorptive activity were significantly reduced by antagonists.
Conclusions:
- The P2X4 receptor plays a crucial role in modulating bone cell function.
- It appears to favor osteogenic lineage commitment over adipogenic differentiation in bone cells.
- P2X4 receptor signaling is important for maintaining bone homeostasis.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
01:40Bone Remodeling
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:16Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:27Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...